Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Hypoxia Inducible Factor 1 (HIF-1) is a heterodimeric transcription factor that plays a central role in cellular adaptation to low oxygen (hypoxic) conditions. It regulates the expression of numerous genes involved in oxygen homeostasis, angiogenesis, metabolism, and cell survival. HIF-1 is composed of an oxygen-sensitive alpha subunit and a constitutively expressed beta subunit. Under hypoxia, the alpha subunit is stabilized and translocates to the nucleus to activate transcription of target genes. It is an important drug target for cancer therapy.
Inhibition of HIF-1alpha subunit stabilization or HIF-1 transcriptional activity.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hypoxia Inducible Factor 1 (HIF-1).